↓ Skip to main content

Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials

Overview of attention for article published in Frontiers in Pharmacology, March 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials
Published in
Frontiers in Pharmacology, March 2021
DOI 10.3389/fphar.2021.603736
Pubmed ID
Authors

Rodolfo Pedro Rothlin, Mariano Duarte, Facundo Germán Pelorosso, Liliana Nicolosi, M. Victoria Salgado, Héctor Miguel Vetulli, Eduardo Spitzer

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 31%
Student > Bachelor 3 12%
Student > Ph. D. Student 2 8%
Student > Master 2 8%
Professor 1 4%
Other 2 8%
Unknown 8 31%
Readers by discipline Count As %
Medicine and Dentistry 5 19%
Biochemistry, Genetics and Molecular Biology 3 12%
Neuroscience 2 8%
Nursing and Health Professions 1 4%
Economics, Econometrics and Finance 1 4%
Other 5 19%
Unknown 9 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 August 2022.
All research outputs
#15,242,689
of 25,483,400 outputs
Outputs from Frontiers in Pharmacology
#5,090
of 19,844 outputs
Outputs of similar age
#227,938
of 454,031 outputs
Outputs of similar age from Frontiers in Pharmacology
#247
of 785 outputs
Altmetric has tracked 25,483,400 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,844 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,031 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 785 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.